Bright Minds Correlations
| DRUG Stock | USD 1.12 0.06 5.08% |
The correlation of Bright Minds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bright Minds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bright Minds Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Good diversification
The correlation between Bright Minds Biosciences and NYA is -0.18 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bright Minds Biosciences and NYA in the same portfolio, assuming nothing else is changed.
Bright |
The ability to find closely correlated positions to Bright Minds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bright Minds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bright Minds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bright Minds Biosciences to buy it.
Moving against Bright Stock
| 0.87 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.81 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.78 | OPT | Opthea | PairCorr |
| 0.74 | SUPN | Supernus Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
| 0.7 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.68 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.62 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
| 0.46 | ELYM | Eliem Therapeutics | PairCorr |
| 0.46 | KROS | Keros TherapeuticsInc Financial Report 2nd of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bright Stock performing well and Bright Minds Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bright Minds' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| REVB | 8.11 | (1.31) | 0.00 | 0.37 | 0.00 | 13.33 | 95.47 | |||
| ZURA | 4.70 | 0.21 | (0.01) | (0.01) | 6.76 | 13.07 | 42.14 | |||
| PHIO | 5.00 | 0.45 | 0.07 | 0.31 | 5.90 | 13.33 | 38.44 | |||
| ZVSA | 5.08 | 0.11 | 0.02 | 0.17 | 5.16 | 10.00 | 45.47 | |||
| RNAZ | 3.79 | (1.23) | 0.00 | (1.35) | 0.00 | 6.90 | 24.77 | |||
| PYXS | 6.49 | 1.10 | 0.22 | 0.31 | 5.87 | 20.75 | 52.82 | |||
| EFTR | 6.74 | (1.52) | 0.00 | (0.22) | 0.00 | 11.60 | 98.22 | |||
| CYTO | 4.54 | (0.59) | 0.00 | (2.16) | 0.00 | 7.73 | 47.75 | |||
| ELEV | 4.91 | 0.68 | 0.16 | 0.59 | 3.95 | 13.28 | 34.99 | |||
| APGN | 3.15 | (0.42) | 0.00 | (11.25) | 0.00 | 6.52 | 19.80 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bright Minds without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Bright Minds Corporate Management
Elected by the shareholders, the Bright Minds' board of directors comprises two types of representatives: Bright Minds inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bright. The board's role is to monitor Bright Minds' management team and ensure that shareholders' interests are well served. Bright Minds' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bright Minds' outside directors are responsible for providing unbiased perspectives on the board's policies.
| FCCP MD | Chief Officer | Profile | |
| Jan MSc | Interim Director | Profile | |
| Emer MBA | Consultant | Profile | |
| Gideon Shapiro | VP Discovery | Profile | |
| Ian McDonald | CEO, CoFounder | Profile |
Already Invested in Bright Minds Biosciences?
The danger of trading Bright Minds Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bright Minds is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bright Minds. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bright Minds Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Bright Stock analysis
When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Return On Assets (0.45) | Return On Equity (0.79) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.